PharmAsia News Notable Notes: Kotak Initiates Coverage Of Five Indian CMO, CRO Firms
This article was originally published in PharmAsia News
Executive Summary
NEW DELHI - Efforts by five smaller Indian drug companies to attract contract research and manufacturing stand to benefit from multinational firms cost-cutting efforts in sourcing active pharmaceutical ingredients and increased clinical trials in the country